
Delia M. Ramirez
Examiner (ID: 4015, Phone: (571)272-0938 , Office: P/1652 )
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1652 |
| Total Applications | 1523 |
| Issued Applications | 823 |
| Pending Applications | 204 |
| Abandoned Applications | 537 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15268133
[patent_doc_number] => 20190382800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => NOVEL CRISPR ENZYMES AND SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 16/450825
[patent_app_country] => US
[patent_app_date] => 2019-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 126499
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16450825
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/450825 | NOVEL CRISPR ENZYMES AND SYSTEMS | Jun 23, 2019 | Pending |
Array
(
[id] => 15268135
[patent_doc_number] => 20190382801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => NOVEL CRISPR ENZYMES AND SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 16/450852
[patent_app_country] => US
[patent_app_date] => 2019-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 126474
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16450852
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/450852 | NOVEL CRISPR ENZYMES AND SYSTEMS | Jun 23, 2019 | Pending |
Array
(
[id] => 16916266
[patent_doc_number] => 20210189358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => METHODS OF MAKING ALKALINE PHOSPHATASE AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/252447
[patent_app_country] => US
[patent_app_date] => 2019-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32554
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17252447
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/252447 | METHODS OF MAKING ALKALINE PHOSPHATASE AGENTS | Jun 16, 2019 | Pending |
Array
(
[id] => 16916266
[patent_doc_number] => 20210189358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => METHODS OF MAKING ALKALINE PHOSPHATASE AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/252447
[patent_app_country] => US
[patent_app_date] => 2019-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32554
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17252447
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/252447 | METHODS OF MAKING ALKALINE PHOSPHATASE AGENTS | Jun 16, 2019 | Pending |
Array
(
[id] => 17052503
[patent_doc_number] => 20210261937
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => SELECTION SYSTEM FOR EVOLVING PROTEASES AND PROTEASE-CLEAVAGE SITES
[patent_app_type] => utility
[patent_app_number] => 17/251266
[patent_app_country] => US
[patent_app_date] => 2019-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21611
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17251266
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/251266 | Protease specific for a novel sumo-derived protease cleavage site | Jun 12, 2019 | Issued |
Array
(
[id] => 20144253
[patent_doc_number] => 12378584
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Methionine analogue synthesis
[patent_app_type] => utility
[patent_app_number] => 17/251742
[patent_app_country] => US
[patent_app_date] => 2019-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 10094
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 294
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17251742
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/251742 | Methionine analogue synthesis | Jun 11, 2019 | Issued |
Array
(
[id] => 20144253
[patent_doc_number] => 12378584
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Methionine analogue synthesis
[patent_app_type] => utility
[patent_app_number] => 17/251742
[patent_app_country] => US
[patent_app_date] => 2019-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 10094
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 294
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17251742
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/251742 | Methionine analogue synthesis | Jun 11, 2019 | Issued |
Array
(
[id] => 16948421
[patent_doc_number] => 20210207112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => PHYTASE MUTANT
[patent_app_type] => utility
[patent_app_number] => 17/059696
[patent_app_country] => US
[patent_app_date] => 2019-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9282
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17059696
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/059696 | Phytase mutant | May 29, 2019 | Issued |
Array
(
[id] => 16557534
[patent_doc_number] => 20210002682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => MODIFIED HOMOSERINE DEHYDROGENASE AND METHOD FOR PRODUCING HOMOSERINE OR L-AMINO ACID DERIVED FROM HOMOSERINE USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/483309
[patent_app_country] => US
[patent_app_date] => 2019-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12377
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16483309
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/483309 | Modified homoserine dehydrogenase and method for producing homoserine or L-amino acid derived from homoserine using the same | May 20, 2019 | Issued |
Array
(
[id] => 15086907
[patent_doc_number] => 20190338264
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => VARIANT AMYLASE ENZYME COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 16/402172
[patent_app_country] => US
[patent_app_date] => 2019-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54680
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16402172
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/402172 | Variant amylase enzyme compositions and methods | May 1, 2019 | Issued |
Array
(
[id] => 15345851
[patent_doc_number] => 20200010817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => NUCLEASE-MEDIATED GENOME EDITING
[patent_app_type] => utility
[patent_app_number] => 16/400021
[patent_app_country] => US
[patent_app_date] => 2019-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8206
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16400021
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/400021 | Nuclease-mediated genome editing | Apr 29, 2019 | Issued |
Array
(
[id] => 15422977
[patent_doc_number] => 10544403
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-28
[patent_title] => Modified transposases for improved insertion sequence bias and increased DNA input tolerance
[patent_app_type] => utility
[patent_app_number] => 16/397542
[patent_app_country] => US
[patent_app_date] => 2019-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 49
[patent_no_of_words] => 22180
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16397542
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/397542 | Modified transposases for improved insertion sequence bias and increased DNA input tolerance | Apr 28, 2019 | Issued |
Array
(
[id] => 15039321
[patent_doc_number] => 20190330665
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => PRODUCTION OF ITACONIC ACID AND RELATED MOLECULES FROM AROMATIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/397256
[patent_app_country] => US
[patent_app_date] => 2019-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14222
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -34
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16397256
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/397256 | Production of itaconic acid and related molecules from aromatic compounds | Apr 28, 2019 | Issued |
Array
(
[id] => 16963254
[patent_doc_number] => 20210214753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => RECOMBINANT CORYNEBACTERIUM HAVING 1,3-PDO PRODUCTIVITY AND REDUCED 3-HP PRODUCTIVITY, AND METHOD FOR PRODUCING 1,3-PDO BY USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/055971
[patent_app_country] => US
[patent_app_date] => 2019-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5777
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17055971
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/055971 | Recombinant | Apr 23, 2019 | Issued |
Array
(
[id] => 15194349
[patent_doc_number] => 10494656
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-03
[patent_title] => Engineered imine reductases and methods for the reductive amination of ketone and amine compounds
[patent_app_type] => utility
[patent_app_number] => 16/391036
[patent_app_country] => US
[patent_app_date] => 2019-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43488
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16391036
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/391036 | Engineered imine reductases and methods for the reductive amination of ketone and amine compounds | Apr 21, 2019 | Issued |
Array
(
[id] => 15086905
[patent_doc_number] => 20190338263
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => OPTIMIZED ENGINEERED MEGANUCLEASES HAVING SPECIFICITY FOR A RECOGNITION SEQUENCE IN THE HEPATITIS B VIRUS GENOME
[patent_app_type] => utility
[patent_app_number] => 16/381668
[patent_app_country] => US
[patent_app_date] => 2019-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34266
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16381668
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/381668 | Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome | Apr 10, 2019 | Issued |
Array
(
[id] => 17513881
[patent_doc_number] => 11293014
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-05
[patent_title] => Microorganism for producing L-amino acid with enhanced activity of a-glucosidase and method for producing L-amino acid using the same
[patent_app_type] => utility
[patent_app_number] => 16/484315
[patent_app_country] => US
[patent_app_date] => 2019-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8146
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16484315
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/484315 | Microorganism for producing L-amino acid with enhanced activity of a-glucosidase and method for producing L-amino acid using the same | Apr 8, 2019 | Issued |
Array
(
[id] => 17421283
[patent_doc_number] => 11254725
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/378163
[patent_app_country] => US
[patent_app_date] => 2019-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22567
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 181
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16378163
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/378163 | Targeted therapeutic lysosomal enzyme fusion proteins and uses thereof | Apr 7, 2019 | Issued |
Array
(
[id] => 14929897
[patent_doc_number] => 20190300586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => ARTIFICIAL FORISOME BODIES WITH SEO-F FUSION PROTEINS, PLANT OR YEAST CELLS WITH VECTORS FOR ENCODING THESE PROTEINS AND VECTORS FOR ENCODING SEO-F FUSION PROTEINS
[patent_app_type] => utility
[patent_app_number] => 16/377019
[patent_app_country] => US
[patent_app_date] => 2019-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8880
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16377019
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/377019 | ARTIFICIAL FORISOME BODIES WITH SEO-F FUSION PROTEINS, PLANT OR YEAST CELLS WITH VECTORS FOR ENCODING THESE PROTEINS AND VECTORS FOR ENCODING SEO-F FUSION PROTEINS | Apr 4, 2019 | Abandoned |
Array
(
[id] => 14581851
[patent_doc_number] => 20190218534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => ALPHA-AMYLASE VARIANT WITH ALTERED PROPERTIES
[patent_app_type] => utility
[patent_app_number] => 16/371361
[patent_app_country] => US
[patent_app_date] => 2019-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18843
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16371361
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/371361 | Alpha-amylase variant with altered properties | Mar 31, 2019 | Issued |